Leishmania major: Protective capacity of DNA vaccine using amastin fused to HSV-1 VP22 and EGFP in BALB/c mice model
Keywords: سالک، لیشمانیوز جلدی، لیشمانیوز پوستی; DNA vaccination; Leishmania; Amastin; Cutaneous leishmaniasis; Herpes simplex virus type1 VP22 (HSV-1 VP22); Green fluorescent protein (GFP);